Ботулинический токсин типа а (Диспорт) в лечении двигательных расстройств

К.Б. Нургалиев · Журнал «Нейрохирургия и неврология Казахстана» · 2012

The botulinus toxin is actively used among neurotoxins since 1989. The wide experience of its application is in this time saved up, the constant analysis of all factors promoting achievement of positive results however is required. As object of research of the author investigated 36 patients (33 men and 3 women) from which 11 patients have been affected by stroke (age 24 61), 11 patients with consequences of spinal and cerebrospinal trauma (age 17-58), 9 patients with consequences of a craniocereberal trauma (age 22-45), 3 patients with a widespread osteochondrosis (age 32-47), 2 the patient after removal of spinal cord lesion(age of 27-50). Injections of Dysport carried out according to the fulfilled and checked up recommendations. The estimation of efficiency of treatment was spent before an injection, and also in 1, 2 and 3 weeks after procedure by means of the modified Ashworth scale. The use of Dysport (1000-1500 units) in complex therapy has shown high efficiency. The combined therapy is most effective.

Cited by 0 works.

Authors